Publications
5808 Results
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), abst. OA 14.07, oral presentation
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S1400, S1400A, S1400B, S1400C, S1400D
Progress in lung squamous cell carcinoma from the Lung-MAP master protocol (S1400) sub-studies S1400A, S1400B, S1400C and S1400D
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), poster presentation, abst. P3.01-046
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S1403
Longitudinal analysis of plasma ctDNA in EGFR-mutant NSCLC: SWOG S1403 trial of afatinib with or without cetuximab
- Journal / Conference
- IASLC World Conference on Lung Cancer (October 15 - 18 2017, Yokohama, Japan), accepted, oral
- Year
- 2017
- Research Committee(s)
- Lung
- Study Number(s)
- S0339, S0342, SWOG-9308, SWOG-9509, S9806
A Clinical Prognostic Model for Survival of Elderly Patients with Non-Small Cell Lung Cancer
- Journal / Conference
- Breast Cancer Research and Treatment Jul;164(2):371-378
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28447237
- PMC
- PMC5798974
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32
- Journal / Conference
- European Society of Medical Oncology (ESMO) 2017 (September 8-12, 2017, Madrid, Spain), poster
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80702
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration
- Journal / Conference
- Annals of Oncology Sep; 28:Supplement abst. 910P, p.323; ESMO Annual Meeting (September 8-12, 2017, Madrid, Spain), poster
- Year
- 2017
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1107
Exome Sequencing of Tumor Tissue Samples Collected from Patients Participating in SWOG S1107 “Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ-197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell carcinoma (pRCC)
- Journal / Conference
- American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Genomic Alterations Important for the Prognosis in Patients with Follicular Lymphoma Treated on SWOG Study S0016
- Journal / Conference
- Blood 130:4033; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
Serum levels of TARC, MDC, IL10 and soluble CD163 in the setting of risk adapted therapy for Hodgkin lymphoma: SWOG S0816 correlative study
- Journal / Conference
- Blood 130:4122; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1001
Characteristics and Outcomes of Patients with Double-Protein Expression in Limited Stage Diffuse Large B-cell Lymphoma (DLBCL): Interim Analysis of SWOG Study S1001 (NCT01359592)
- Journal / Conference
- Blood 130:1553; American Society of Hematology Annual Meeting (December 9-12, 2017, Atlanta, GA), poster
- Year
- 2017
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1001